Cureline's acquisition protocols for the collection of clinically-defined neurological specimens currently include the following conditions:
Postmortem collection of S. nigra from patients diagnosed with Parkinson's disease
Postmortem collection of hypothalamus from patients diagnosed with Alzheimer's disease
Collection of Central Spinal Fluid (CSF) and blood from patients diagnosed with Multiple Sclerosis
Cureline is developing a network of clinical research centers for collecting difficult to procure biospecimens. To inquire about the current availability of specimens or to investigate your project feasibility, contact our office or send us an inquiry via email.